Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT00683696
Registration number
NCT00683696
Ethics application status
Date submitted
30/08/2007
Date registered
23/05/2008
Date last updated
17/01/2018
Titles & IDs
Public title
Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)
Query!
Scientific title
Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)
Query!
Secondary ID [1]
0
0
EchoCRT
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
EchoCRT
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Heart Failure
0
0
Query!
Ventricular Dyssynchrony
0
0
Query!
Condition category
Condition code
Cardiovascular
0
0
0
0
Query!
Coronary heart disease
Query!
Cardiovascular
0
0
0
0
Query!
Other cardiovascular diseases
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment: Devices - Implantable Cardioverter Defibrillator with Cardiac Resynchronization Therapy (BIOTRONIK Lumax HF-T CRT-D)
Experimental: CRT=ON - Cardiac Resynchronization Therapy activated.
Active comparator: CRT=OFF - Cardiac Resynchronization Therapy deactivated.
Treatment: Devices: Implantable Cardioverter Defibrillator with Cardiac Resynchronization Therapy (BIOTRONIK Lumax HF-T CRT-D)
All patients will receive a commercially available BIOTRONIK Lumax HF-T CRT-D system with ICD back-up enabled. Patients will be randomized to CRT=ON or CRT=OFF.
Query!
Intervention code [1]
0
0
Treatment: Devices
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Composite Primary Endpoint: Number of Subjects With First Hospitalization for Worsening Heart Failure or Death
Query!
Assessment method [1]
0
0
The primary efficacy endpoint will evaluate the effect of CRT=ON versus CRT=OFF in time to event of a combined endpoint of all-cause mortality or first hospitalization for worsening heart failure.
Query!
Timepoint [1]
0
0
From date of randomization until date of death from any cause or date of first hospitalization for worsening heart failure, whichever came first, assessed up to date of study exit, with a mean treatment duration of 1.6 years
Query!
Primary outcome [2]
0
0
Number of Subjects That Underwent Implant Attempt Without System- or Implant-Related Complications (Complication-Free)
Query!
Assessment method [2]
0
0
The primary safety endpoint will evaluate the complication-free rate of the Lumax HF-T CRT-D devices in the narrow QRS subject population.
Query!
Timepoint [2]
0
0
6 months
Query!
Secondary outcome [1]
0
0
Rate of Hospitalizations for Worsening Heart Failure (Hospitalizations Per Subject-year)
Query!
Assessment method [1]
0
0
Evaluate the effects of CRT=ON compared to CRT=OFF on the rate of hospitalization for worsening heart failure (WHF).
Query!
Timepoint [1]
0
0
Study duration from randomization to study exit
Query!
Secondary outcome [2]
0
0
New York Heart Association (NYHA) Classification Change
Query!
Assessment method [2]
0
0
Evaluate the effects of CRT=ON compared to CRT=OFF in relation to the change in NYHA classification.
NYHA classes:
Class I - Subjects with cardiac disease, but without resulting limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation,dyspnea, or anginal pain.
Class II - Subjects with cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or anginal pain.
Class III - Subjects with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest. Less than ordinary activity causes fatigue, palpitation, dyspnea, or anginal pain.
Class IV - Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency or of anginal syndrome may be present even at rest. If any physical activity is undertaken, discomfort is increased.
Query!
Timepoint [2]
0
0
6 months
Query!
Secondary outcome [3]
0
0
Change in Quality of Life (QOL) Scores From Baseline to 6-Month Follow-up
Query!
Assessment method [3]
0
0
Quality of Life was evaluated using the Minnesota Living with Heart Failure (MLHF) Quality of Life (QOL) Questionnaire.The questionnaire consists of 21 questions to measure the subjects' perception of how their HF and its treatment affected their ability to live as they wanted during the last month. The questions describe different ways in which some people are affected (i.e. physical, socioeconomic, and psychological impairments). If a question does not apply to a subject or is not related to their HF, then they can answer with a 0. If it does apply to them, then they can rate (from 1 to 5) how much it has affected them. From the 21 questions, the lowest possible total score is 0, and the highest possible total score is 105. A lower score is desirable. Therefore, a negative change in QOL score from baseline to 6 months represents an improvement in quality of life, while a positive change in QOL score from baseline to 6 months represents a worsening in quality of life.
Query!
Timepoint [3]
0
0
Changes between baseline and 6 months
Query!
Secondary outcome [4]
0
0
Composite Score of Death, Hospitalization for Worsening Heart Failure and Change in Quality of Life (QOL)
Query!
Assessment method [4]
0
0
Evaluate the effects of CRT=ON compared to CRT=OFF in relation to a composite endpoint of all-cause mortality, hospitalization for worsening heart failure and change in the MLHF Quality of Life Questionnaire.
This composite endpoint used a weighted scoring scale based on the African-American Heart Failure Trial (A-HeFT) study Endpoint Score. (Taylor, AL, Ziesche, S, Yancy, C, et al. Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure. N Engl J Med 2004; 351:2049-57.)
Composite Endpoint Scoring:
Vital Status:
Death (-3),
Survival to end of trial (0),
Hospitalization:
1st hospitalization for HF (-1),
No hospitalization (0),
QOL score:\*
Improvement by = 10 units (+2),
Improvement by 5-9 units (+1),
Change by \< 5 units (0),
Worsening by 5-9 units (-1),
Worsening by = 10 (-2).
Possible total score -6 to +2.
\*QOL score details are provided in Secondary Outcome Measure 5.
Query!
Timepoint [4]
0
0
Composite of death, worsening heart failure hospitalization (up to 24 months), and change in QOL (at 6 months)
Query!
Secondary outcome [5]
0
0
Number of Subjects With All-cause Mortality
Query!
Assessment method [5]
0
0
Evaluate the all-cause mortality rate between the CRT=ON compared to CRT=OFF group.
Query!
Timepoint [5]
0
0
From date of randomization up to date of study exit, with a mean treatment duration of 1.6 years
Query!
Eligibility
Key inclusion criteria
* Men and women 18 years of age or older.
* Understand the nature of the procedure.
* Give written informed consent.
* Willing and able to complete all testing required by the clinical protocol.
* Indication for an implantable cardioverter defibrillator (ICD).
* NYHA class III-IV within the last three months prior to enrollment and at baseline (at baseline only: also Stage C according to ACC/AHA guidelines).
* Stable optimal pharmacologic therapy for HF.
* An ejection fraction = 35% within one year prior to enrollment and confirmed on the baseline echocardiogram.
* Increased left ventricular dimension, defined as LVEDD = 55 mm.
* Resting QRS duration < 130 ms evidenced by a historical 12-lead ECG prior to enrollment and at baseline.
* Ventricular dyssynchrony assessed by echocardiography locally and confirmed by the echo core lab. One of the two following criteria has to be present to include the subject in the study:
* Intra-left ventricular dyssynchrony measured by color Tissue Doppler Imaging (TDI) with an opposing wall delay of = 80 ms in the 4-chamber or apical long-axis view.
* Speckle-tracking radial strain septal-posterior wall delay = 130 ms.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
* Implanted pacemaker or defibrillator with >10% ventricular pacing, as demonstrated by device statistics averaged over at least the last three months prior to enrollment.
* Women who are pregnant, lactating, or planning to become pregnant during the course of the trial.
* Bradycardia pacing indication.
* Surgically correctable primary valvular heart disease, i.e. aortic stenosis, torn cordae, or flail segment.
* Coronary artery bypass graft surgery or percutaneous coronary intervention (balloon and/or stent angioplasty) within the past 3 months prior to enrollment.
* Enzyme-positive myocardial infarction within the past 3 months prior to enrollment.
* Angiographic evidence of coronary disease, candidates for coronary revascularization likely to undergo coronary artery bypass graft surgery or percutaneous coronary intervention in the next 3 months.
* Irreversible brain damage from preexisting cerebral disease.
* Reversible non-ischemic cardiomyopathy such as acute viral myocarditis.
* Permanent second or third degree heart block.
* Chagas disease.
* Persistent or paroxysmal atrial fibrillation within one month prior to enrollment.
* Expected to receive heart transplantation within six months.
* Current inotropic therapy.
* Acutely decompensated heart failure.
* Contrast dye allergy and unable or unwilling to undergo pretreatment with steroids and/or diphenhydramine.
* Life expectancy of less than six months.
* Presence of any disease, other than the subject's cardiac disease associated with a reduced likelihood of survival for the duration of the trial, (e.g. cancer).
* Significant renal insufficiency defined as a serum creatinine > 2.5 mg/dL (> 221 µmol/L) within the last four weeks prior to enrollment..
* Liver failure, defined as three times the upper limit of normal for aminotransferases.
* Participation in any other clinical trial.
* Unable to return for follow-up visits due to distance from the clinic.
* Do not anticipate being a resident of the area for the scheduled duration of the trial.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people assessing the outcomes
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 2
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Stopped early
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/08/2008
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
1/03/2013
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
1680
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Recruitment hospital [1]
0
0
Flinders Medical Center Adelaide - Adelaide
Query!
Recruitment hospital [2]
0
0
Princess Alexandra Hospital - Brisbane
Query!
Recruitment hospital [3]
0
0
St. Vincent's Hospital - Melbourne
Query!
Recruitment hospital [4]
0
0
Sir Charles Gairdner Hospital - Nedland
Query!
Recruitment hospital [5]
0
0
Royal Perth Hospital - Perth
Query!
Recruitment postcode(s) [1]
0
0
- Adelaide
Query!
Recruitment postcode(s) [2]
0
0
- Brisbane
Query!
Recruitment postcode(s) [3]
0
0
- Melbourne
Query!
Recruitment postcode(s) [4]
0
0
- Nedland
Query!
Recruitment postcode(s) [5]
0
0
- Perth
Query!
Recruitment outside Australia
Country [1]
0
0
United States of America
Query!
State/province [1]
0
0
California
Query!
Country [2]
0
0
United States of America
Query!
State/province [2]
0
0
Connecticut
Query!
Country [3]
0
0
United States of America
Query!
State/province [3]
0
0
Florida
Query!
Country [4]
0
0
United States of America
Query!
State/province [4]
0
0
Georgia
Query!
Country [5]
0
0
United States of America
Query!
State/province [5]
0
0
Illinois
Query!
Country [6]
0
0
United States of America
Query!
State/province [6]
0
0
Indiana
Query!
Country [7]
0
0
United States of America
Query!
State/province [7]
0
0
Kentucky
Query!
Country [8]
0
0
United States of America
Query!
State/province [8]
0
0
Massachusetts
Query!
Country [9]
0
0
United States of America
Query!
State/province [9]
0
0
Michigan
Query!
Country [10]
0
0
United States of America
Query!
State/province [10]
0
0
Minnesota
Query!
Country [11]
0
0
United States of America
Query!
State/province [11]
0
0
Mississippi
Query!
Country [12]
0
0
United States of America
Query!
State/province [12]
0
0
Missouri
Query!
Country [13]
0
0
United States of America
Query!
State/province [13]
0
0
New Jersey
Query!
Country [14]
0
0
United States of America
Query!
State/province [14]
0
0
New York
Query!
Country [15]
0
0
United States of America
Query!
State/province [15]
0
0
North Carolina
Query!
Country [16]
0
0
United States of America
Query!
State/province [16]
0
0
Ohio
Query!
Country [17]
0
0
United States of America
Query!
State/province [17]
0
0
Oregon
Query!
Country [18]
0
0
United States of America
Query!
State/province [18]
0
0
Pennsylvania
Query!
Country [19]
0
0
United States of America
Query!
State/province [19]
0
0
South Carolina
Query!
Country [20]
0
0
United States of America
Query!
State/province [20]
0
0
Tennessee
Query!
Country [21]
0
0
United States of America
Query!
State/province [21]
0
0
Texas
Query!
Country [22]
0
0
United States of America
Query!
State/province [22]
0
0
Virginia
Query!
Country [23]
0
0
United States of America
Query!
State/province [23]
0
0
Washington
Query!
Country [24]
0
0
United States of America
Query!
State/province [24]
0
0
Wisconsin
Query!
Country [25]
0
0
Austria
Query!
State/province [25]
0
0
Graz
Query!
Country [26]
0
0
Belgium
Query!
State/province [26]
0
0
Aalst
Query!
Country [27]
0
0
Belgium
Query!
State/province [27]
0
0
Brussels
Query!
Country [28]
0
0
Canada
Query!
State/province [28]
0
0
Ontario
Query!
Country [29]
0
0
Canada
Query!
State/province [29]
0
0
Edmonton
Query!
Country [30]
0
0
Czechia
Query!
State/province [30]
0
0
Olomouc
Query!
Country [31]
0
0
Czechia
Query!
State/province [31]
0
0
Prague
Query!
Country [32]
0
0
Denmark
Query!
State/province [32]
0
0
Aalborg
Query!
Country [33]
0
0
Denmark
Query!
State/province [33]
0
0
Aarhus
Query!
Country [34]
0
0
Denmark
Query!
State/province [34]
0
0
Copenhagen
Query!
Country [35]
0
0
Denmark
Query!
State/province [35]
0
0
Hellerup
Query!
Country [36]
0
0
France
Query!
State/province [36]
0
0
Nantes
Query!
Country [37]
0
0
France
Query!
State/province [37]
0
0
Rennes
Query!
Country [38]
0
0
France
Query!
State/province [38]
0
0
Rouen
Query!
Country [39]
0
0
Germany
Query!
State/province [39]
0
0
Bad Oeynhausen
Query!
Country [40]
0
0
Germany
Query!
State/province [40]
0
0
Berlin
Query!
Country [41]
0
0
Germany
Query!
State/province [41]
0
0
Bernau
Query!
Country [42]
0
0
Germany
Query!
State/province [42]
0
0
Essen
Query!
Country [43]
0
0
Germany
Query!
State/province [43]
0
0
Hamburg
Query!
Country [44]
0
0
Germany
Query!
State/province [44]
0
0
Jena
Query!
Country [45]
0
0
Germany
Query!
State/province [45]
0
0
Leipzig
Query!
Country [46]
0
0
Germany
Query!
State/province [46]
0
0
Lunen
Query!
Country [47]
0
0
Germany
Query!
State/province [47]
0
0
Lüdenscheid
Query!
Country [48]
0
0
Germany
Query!
State/province [48]
0
0
Magdeburg
Query!
Country [49]
0
0
Israel
Query!
State/province [49]
0
0
Ashkelon
Query!
Country [50]
0
0
Israel
Query!
State/province [50]
0
0
Beer Sheva
Query!
Country [51]
0
0
Israel
Query!
State/province [51]
0
0
Jerusalem
Query!
Country [52]
0
0
Israel
Query!
State/province [52]
0
0
Tel Aviv
Query!
Country [53]
0
0
Israel
Query!
State/province [53]
0
0
Tel Hashomer
Query!
Country [54]
0
0
Italy
Query!
State/province [54]
0
0
Bari
Query!
Country [55]
0
0
Italy
Query!
State/province [55]
0
0
Brescia
Query!
Country [56]
0
0
Italy
Query!
State/province [56]
0
0
Naples
Query!
Country [57]
0
0
Italy
Query!
State/province [57]
0
0
Novara
Query!
Country [58]
0
0
Netherlands
Query!
State/province [58]
0
0
Amsterdam
Query!
Country [59]
0
0
Netherlands
Query!
State/province [59]
0
0
Leiden
Query!
Country [60]
0
0
Poland
Query!
State/province [60]
0
0
Warsaw
Query!
Country [61]
0
0
Poland
Query!
State/province [61]
0
0
Wroclaw
Query!
Country [62]
0
0
Portugal
Query!
State/province [62]
0
0
Lisbon
Query!
Country [63]
0
0
Spain
Query!
State/province [63]
0
0
Alicante
Query!
Country [64]
0
0
Spain
Query!
State/province [64]
0
0
Barcelona
Query!
Country [65]
0
0
Switzerland
Query!
State/province [65]
0
0
Geneve
Query!
Country [66]
0
0
Switzerland
Query!
State/province [66]
0
0
Lausanne
Query!
Country [67]
0
0
Switzerland
Query!
State/province [67]
0
0
Zurich
Query!
Country [68]
0
0
United Kingdom
Query!
State/province [68]
0
0
Coventry
Query!
Country [69]
0
0
United Kingdom
Query!
State/province [69]
0
0
Leicester
Query!
Country [70]
0
0
United Kingdom
Query!
State/province [70]
0
0
London
Query!
Country [71]
0
0
United Kingdom
Query!
State/province [71]
0
0
West Midlands
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Query!
Name
Biotronik, Inc.
Query!
Address
Query!
Country
Query!
Other collaborator category [1]
0
0
Other
Query!
Name [1]
0
0
University of Zurich
Query!
Address [1]
0
0
Query!
Country [1]
0
0
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
The EchoCRT trial evaluates the effects of Cardiac Resynchronization Therapy (CRT) on mortality and morbidity of subjects with heart failure due to left ventricular systolic dysfunction, already receiving optimized HF medication, with a narrow QRS width (\< 130 ms) and echocardiographic evidence of ventricular dyssynchrony.
Query!
Trial website
https://clinicaltrials.gov/study/NCT00683696
Query!
Trial related presentations / publications
Varma N, Sogaard P, Bax JJ, Abraham WT, Borer JS, Dickstein K, Singh JP, Gras D, Holzmeister J, Brugada J, Ruschitzka F. Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial. J Am Heart Assoc. 2018 May 27;7(11):e009592. doi: 10.1161/JAHA.118.009592. Erratum In: J Am Heart Assoc. 2018 Jun 17;7(12):e004259. doi: 10.1161/JAHA.117.004259. Tayal B, Gorcsan J 3rd, Bax JJ, Risum N, Olsen NT, Singh JP, Abraham WT, Borer JS, Dickstein K, Gras D, Krum H, Brugada J, Robertson M, Ford I, Holzmeister J, Ruschitzka F, Sogaard P. Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes. J Am Coll Cardiol. 2018 Mar 27;71(12):1325-1333. doi: 10.1016/j.jacc.2018.01.042. Steffel J, Varma N, Robertson M, Singh JP, Bax JJ, Borer JS, Dickstein K, Ford I, Gorcsan J 3rd, Gras D, Krum H, Sogaard P, Holzmeister J, Brugada J, Abraham WT, Ruschitzka F. Effect of Gender on Outcomes After Cardiac Resynchronization Therapy in Patients With a Narrow QRS Complex: A Subgroup Analysis of the EchoCRT Trial. Circ Arrhythm Electrophysiol. 2016 Jun;9(6):e003924. doi: 10.1161/CIRCEP.115.003924. Ruschitzka F, Abraham WT, Singh JP, Bax JJ, Borer JS, Brugada J, Dickstein K, Ford I, Gorcsan J 3rd, Gras D, Krum H, Sogaard P, Holzmeister J; EchoCRT Study Group. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med. 2013 Oct 10;369(15):1395-405. doi: 10.1056/NEJMoa1306687. Epub 2013 Sep 2.
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Frank Ruschitzka, MD
Query!
Address
0
0
University of Zurich, Switzerland
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
No documents have been uploaded by study researchers.
Results are available at
https://clinicaltrials.gov/study/NCT00683696
Download to PDF